MyFinsight

HomeCompareAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Privacy Policy
  • Contact

Follow Us

  • Thread
  • X.com
  • Instagram

© 2026 MyFinsight. All rights reserved.

Recent SEC Filings
10/2NIKE, Inc.(NKE)10/2DARDEN RESTAURANTS INC(DRI)9/30CONAGRA BRANDS INC.(CAG)9/29Carnival Corp Ltd.(CCL)9/29URANIUM ENERGY CORP(UEC)9/29COPART INC(CPRT)9/24BLACKBERRY Ltd(BB)9/24PAYCHEX INC(PAYX)9/23GENERAL MILLS INC(GIS)9/22ADOBE INC.(ADBE)9/18KROGER CO(KR)10/2NIKE, Inc.(NKE)10/2DARDEN RESTAURANTS INC(DRI)9/30CONAGRA BRANDS INC.(CAG)9/29Carnival Corp Ltd.(CCL)9/29URANIUM ENERGY CORP(UEC)9/29COPART INC(CPRT)9/24BLACKBERRY Ltd(BB)9/24PAYCHEX INC(PAYX)9/23GENERAL MILLS INC(GIS)9/22ADOBE INC.(ADBE)9/18KROGER CO(KR)
||
||

Balance Sheets Overview

Current Ratio
0.16%
Quick Ratio
0.16%
Cash Ratio
0.00%
Debt to Asset Ratio
77952.78%
Unit: Dollar
Assets Breakdown
    • Prepaid expenses and other curre...
    • Cash and cash equivalents
Liabilities Breakdown
    • Accumulated deficit
    • Accrued compensation
    • Additional paid-in capital
    • Others
Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Prepaid expenses and other current assets
-
-
23,537
4,116
Cash and cash equivalents
72
3,622
31,761
53,583
Prepaid expenses and other current assets
9,756
16,260
-
-
Total current assets
9,828
19,882
55,298
57,699
Total assets
9,828
19,882
55,298
57,699
Accounts payable
167,058
132,784
133,759
133,808
Accrued compensation
4,370,369
4,254,208
4,135,109
4,011,998
Accrued consulting
787,903
787,903
787,903
787,903
Accrued expenses and other
651,940
655,160
658,047
636,632
Loan payable
200,000
200,000
200,000
200,000
Total current liabilities
6,177,270
6,030,055
5,914,818
5,770,341
Convertible notes, net
1,483,929
1,465,847
1,447,363
1,428,880
Total liabilities
7,661,199
7,495,902
7,362,181
7,199,221
Preferred stock, value-Series APreferred Stock
0
0
0
0
Preferred stock, value
-
-
-
0
Preferred stock, value-Series BPreferred Stock
1
1
1
1
Common stock, 0.00001 par value 100,000,000 shares authorized 7,242,137 shares issued and outstanding
72
72
72
72
Additional paid-in capital
2,050,073
2,050,073
2,050,073
2,050,073
Accumulated deficit
-9,701,517
-9,526,166
-9,357,029
-9,191,668
Total stockholders deficit
-7,651,371
-7,476,020
-7,306,883
-7,141,522
Total liabilities and stockholders deficit
9,828
19,882
55,298
57,699
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

CPMV Balance Sheet Sankey DiagramSankey diagram visualizing CPMV balance sheet for the periodPrepaid expenses andother current assets$9,756 Cash and cashequivalents$72 Total current assets$9,828 Total assets$9,828 Accumulated deficit-$9,701,517 Total liabilities andstockholders deficit$9,828 Total stockholdersdeficit-$7,651,371 Additional paid-in capital$2,050,073 Common stock, 0.00001par value...$72 Preferred stock,value-Series BPreferred...$1 Total liabilities$7,661,199 Total currentliabilities$6,177,270 Convertible notes, net$1,483,929 Accrued compensation$4,370,369 Accrued consulting$787,903 Accrued expenses andother$651,940 Loan payable$200,000 Accounts payable$167,058

Mosaic ImmunoEngineering Inc. (CPMV)

Mosaic ImmunoEngineering Inc. (CPMV)